Bortezomib Induction and Maintenance Treatment Improves Survival In Patients With Newly Diagnosed Multiple Myeloma:Extended Follow-Up Of The HOVON-65/GMMG-HD4 Trial
Year: 2013
Type: article
Source: Blood
Authors: Pieter Sonneveld, Christof Scheid, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Hans Salwender, Sonja Zweegman, Edo Vellenga, Annemiek Broyl, Igor Wolfgang Blau, Katja Weisel, Shulamit Wittebol, Gerard M.J. Bos, Marjan Stevens, Ingo GH Schmidt-Wolf, Michael Pfreundschuh, Dirk Hose, Anna Jauch, Helgi van de Velde, Reinier Raymakers, Martyn Ronald Schaafsma, Marie Jose Kersten, Marinus van Marwijk Kooy, Ulrich Duehrsen, Hans Walter Lindemann, Pierre W. Wijermans, Henk Lokhorst, H. Goldschmidt
Institutions: Erasmus MC Cancer Institute, Daniel den Hoed Kliniek, Erasmus MC, University Hospital Heidelberg, Asklepios Klinik Altona, Amsterdam UMC Location Vrije Universiteit Amsterdam, University Medical Center Groningen, Charité – Universitätsmedizin Berlin, University of Tübingen, Hovon, Maastricht University Medical Centre, University of Bonn, Saarland University, Janssen (Belgium), University Medical Center Utrecht, Medisch Spectrum Twente, Amsterdam UMC Location University of Amsterdam, Isala, Haga Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1496735223